In vitro expansion of the adult human bone marrow mesenchymal stem cells for clinic application in HSCT.
- Author:
Wen-Yong KUANG
1
;
Xin-Fu ZHOU
;
Guang-Sen ZHANG
;
Li-Hua LIU
;
Shao-Fang CHEN
;
Rui-Juan LI
;
Le XIAO
Author Information
1. Department of Hematology, Xiangya Second Hospital, Central South University, Changsha 410011, Hunan Province, China.
- Publication Type:Journal Article
- MeSH:
Adult;
Bone Marrow Cells;
cytology;
Cell Culture Techniques;
methods;
Cell Differentiation;
physiology;
Cell Proliferation;
Cells, Cultured;
Culture Media;
Female;
Fetal Blood;
Humans;
Male;
Mesenchymal Stem Cell Transplantation;
Mesenchymal Stromal Cells;
cytology;
Middle Aged;
Serum
- From:
Journal of Experimental Hematology
2008;16(3):633-638
- CountryChina
- Language:Chinese
-
Abstract:
This study was aimed to investigate the efficiency of 4 different culture media for in vitro culture and expanding adult human bone marrow mesenchymal stem cells (ahBM-MSCs) so as to establish a protocol of culturing and expanding hBM-MSCs and provide exprimental basis for hematopoietic blood stem cell transplantation combined with BM-MSCs. BM-MSCs were obtained from 16 fresh adult human bone marrow aspirate by gradient centrifugation with Ficoll Paque, then cultured in DMEM/F12 with 10% umbilical cord blood serum, 10% fetal calf serum (FCS), human blood serum, and MesenCult culture medium. The surface antigens of BM-MSCs were detected by flow cytometry. BM-MSCs were differentiated into osteoblasts and adipocytes under culture in the conditioned medium special for osteogenesis, and adipogenesis and the differentiated MSCs were identified by morphological observation, immunophenotype and immunohistochemical staining. The results showed that BM-MSCs could be isolated from adult human bone marrow and cultured by all culture media. The effect of umbilical cord blood serum on BM-MSC proliferation and their purity were similar to that of MesenCult culture medium, but better than that of FCS and human blood serum. The positive rate of CD29, CD73, CD105 on BM-MSCs cultured in umbilical cord serum and MesenCult medium was higher than that in FCS and adult human serum (p < 0.05), and the positive rate of CD31 was lower than that in FCS and adult human serum (p < 0.05). The positive rate of BM-MSCs differentiated into osteoblasts and adipocytes under culture in the conditioned medium for osteogenesis and adipogenesis with umbilical cord blood serum and MesenCult culture medium was also higher than that in FCS and adult human serum (p < 0.05). It is concluded that BM-MSCs can be obtained by all the four methods. DMEM/F12 with 10% umbilical cord blood serum and MesenCult culture medium are better than the others for the purification and differentiation potency of BM-MSCs in vitro. The medium with umbilical cord serum is valuable for clinical application in HSCT.
